Search jobs

#DYK as we age, our immune system ages, too? A shift in mindset towards lifelong immunisation would help ensure adults are protected against vaccine-preventable diseases. #WIW2023 #TheBigCatchUp Learn more: gsk.com/en-gb/behind-t…

An estimated 3.5 to 5 million lives are saved every year thanks to #immunisation. Help protect future generations from vaccine-preventable diseases. #WIW2023 #TheBigCatchUp

At GSK and @ViiVHC, we believe partnership makes us stronger🤝Partnership can help to build trust within communities where it’s needed most. At the heart of these partnerships are passionate people like Makeletso.🖊Comment below how you’ve been supported by your local communityGM

As the #WHISEU 2023 official Oncology Partner, we're looking forward to discussing how to improve access to care for people with gynaecologic #cancer via disease education, empowering self-advocacy and collaboration. Learn more about our work 👇

We feel privileged to connect with the #myelofibrosis community. In a recent issue, @RareRevolutionM shares insights from @MPN_RF on the progress made and where we can get #AheadTogether next.

Did you know that #AntimicrobialResistance could result in 10 million deaths every year by 2050? Go Behind the Science to learn more about #AMR 👇 gsk.to/41b2SNSR

Every medicine that leaves GSK and reaches a patient goes through our Medicine Development and Supply team. Learn how our dedicated MDS team are getting ahead of disease together. #AheadTogether

#News for #investors and #media: Today we announced the proposed acquisition of @BELLUSHealth, a clinical stage biopharmaceutical company that further strengthens our specialty medicines and respiratory pipeline. Find out more: gsk.to/40jdUj1

Did you know that the immune system becomes less effective in defending us from infectious diseases like #shingles as we age? Go Behind the Science and learn more about age-related decline in immunity: gsk.to/40fMn1Z #ECCMID2023

#News for #investors and #media: Today we have announced positive pivotal phase III data for our antibiotic candidate for the potential treatment of uncomplicated UTIs. Find out more: gsk.com/en-gb/